Expands Medicare drug price negotiation powers

File SF5302 ("Expands Medicare drug price negotiation powers") is before the Minnesota Legislature and has not been decided. Latest step (May 16, 2026): Introduction and first reading.

Minnesota file SF5302, before the Minnesota Legislature. Still to be decided as of 2026-05-16.

What it does

Medicare recipients may see lower drug costs sooner If Minnesota adopts federal negotiation standards, seniors on Medicare could access price-negotiated drugs faster than current federal timeline, though specific savings depend on which drugs enter negotiation.

The bigger picture

State and federal drug pricing rules could align or conflict Minnesota state-level drug price negotiation aligned with Medicare's program could streamline pharmacy operations across state lines but may also trigger federal-state legal disputes over negotiation authority.

What to watch

Pharma companies may reduce drug availability or innovation Drug manufacturers have warned that expanded negotiation authority (state or federal) could discourage new drug development or cause shortages in smaller markets like Minnesota.

Official summary

Prescription drugs prices establishment subject to the Medicare Drug Price Negotiation Program

Read the official record for SF5302

See everything up for a vote · This week in Minnesota · See what we have filed with the clerk